Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants
Tóm tắt
Background: Recently, experimental zinc deficiency has been correlated with depression-like alterations in rodents. Methods: In the first part of present study, the time course of zinc deficient diet induced alterations in the tail suspension test (TST) in mice was investigated. In the second part, the effect of imipramine and escitalopram in control and zinc-deprived for 3 weeks mice was examined in the TST. Results: A4- and 10-week administration of a Zn-deficient diet enhanced the immobility time in the TST (by 20% and 57%, respectively). By contrast, a 2-week period of a zinc deficient diet effected the reduction (by 24%) of the immobility time. Moreover, a 2- and 4-week (but not 10-week) of a Zn-deficient diet resulted in the reduction of the body weight (by 37% and 18%, respectively). These results indicate the developing response to zinc deficiency induced by a zinc-deficient diet. The antidepressant-like effect (reduction in the immobility time) of both drugs was significantly reduced in zinc-deprived mice, which suggests treatment-resistance induced by zinc deprivation. Conclusion: Zinc deprivation induces “pro-depressive” behavior and alters antidepressant efficacy.
Tài liệu tham khảo
Brocardo PS, Assini F, Franco JL, Pandolfo P, Müller YM, Takahashi RN, Dafre AL, Rodrigues AL: Zinc attenuates malathion-induced depressant-like behavior and confers neuroprotection in the rat brain. Toxicol Sci, 2007, 97, 140–148.
Brown KH, Wuehler SE, Peerson JM: The importance of zinc in human nutrition and estimation of the global prevalence of zinc deficiency. Food Nutr Bull, 2001, 22, 113–125.
Cieślik K, Klenk-Majewska B, Danilczuk Z, Wróbel A, Łupina T, Ossowska G: Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol Rep, 2007, 59, 46–52.
Cunha MP, Machado DG, Bettio LEB, Capra JC, Rodrigues ALS: Interaction of zinc with antidepressants in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32, 1913–1920.
Danbolt NC: Glutamate uptake. Prog Neurobiol, 2001, 65, 1–105.
Jokinen J, Nordström P: HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affect Disord, 2009, 116, 117–120.
Kroczka B, Brański P, Pałucha A, Pilc A, Nowak G: Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull, 2001, 55, 297–300.
Kroczka B, Zięba A, Dudek D, Pilc A, Nowak G: Zinc exhibits an antidepressant like effect in the forced swimming test in mice. Pol J Pharmacol, 2000, 52, 403–406.
Levenson CW: Zinc regulation of food intake: new insights on the role of neuropeptide Y, Nutr Rev, 2003, 61, 247–249.
Levenson CW: Zinc: the new antidepressant? Nutr Rev, 2006, 64, 39–42.
Maes M, D’Haese PC, Scharpe S, D’Hondt PD, Cosyns P, De Broe ME: Hipozincemia in depression. J Affect Disord, 1994, 31, 135–140.
Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, Altamura C, Desnyder R: Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness, Biol Psychiatry, 1997, 42, 49–358.
McLoughlin IJ, Hodge JS: Zinc in depressive disorder. Acta Psychiatr Scand, 1990, 82, 451–453.
Moghaddam B, Bolinao ML, Stein-Behrens B, Sapolsky R: Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Res, 1994, 655, 251–254.
Nowak G, Siwek M, Dudek D, Zięba A, Pilc A: Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study, Pol J Pharmacol, 2003, 55, 1143–1147.
Nowak G, Szewczyk B, Pilc A: Zinc and depression. An update. Pharmacol Rep, 2005, 57, 713–718.
Nowak G, Szewczyk B, Wierońska JM, Brański P, Pałucha A, Pilc A, Sadlik K, Piekoszewski W: Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull, 2003, 61, 159–164.
Opoka W, Sowa-Kućma M, Stachowicz K, Ostachowicz B, Szlósarczyk M, Stypuła A, Młyniec K et al.: Early life time zinc supplementation protects zinc-deficient dietinduced alterations. Pharmacol Rep, 2010, 62, 1211–1217.
Paoletti P, Ascher P, Neyton J: High-affinity zinc inhibition of NMDA NR1-NR2 receptors. J Neurosci, 1997, 17, 5711–5725.
Rosa AO, Lin J, Calixto JB, Santos ARS, Rodrigues ALS: Involvement of NMDA receptors and L-argininenitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res, 2003, 144, 87–93.
Sawada T, Yokoi K: Effect of zinc supplementation on mood states in young women: a pilot study. Eur J Nutr, 2010, 64, 331–333.
Sensi SL, Paoletti P, Bush AI, Sekler I: Zinc in the physiology and pathology of the CNS. Nat Rev Neurosci, 2009, 10, 780–791.
Siwek M, Dudek D, Paul JA, Sowa-Kućma M, Zięba A, Popik P, Pilc A, Nowak G: Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study. J Affect Disord, 2009, 118, 187–195.
Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, Zięba A et al.: Serum zimc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord, 2010, 126, 447–452.
Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression, Pharmacopsychiatry, 1996, 29, 23–26.
Skolnick P, Legutko B, Li X, Bymaster F: Current perspectives on the development of non-biogenic amine based antidepressants, Pharmacol Res, 2001, 43, 411–423.
Skolnick P, Popik P, Trullas R: Glutamate-based antidepressants: 2 years on. Trends Pharmacol Sci, 2009, 30, 563–569.
Skolnick P, Popik P, Trullas R: N-Methyl-D-Aspartate (NMDA) Antagonists for the Treatment of Depression, in Glutamate-based Therapies for Psychiatric Disorders. Ed. Skolnick P., Springer Basel AG, 2010, 1–20.
Sowa-Kućma M, Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E, Papp M et al.: Antidepressant-like activity of zinc: further behavioural and molecular evidence. J Neural Transm, 2008, 115, 1621–1628.
Steru L, Chermat R, Thierry B, Simon P: The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology, 1985, 85, 367–370.
Stokes PE: The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. Eur Neuropsychopharmacol, 1995, 5, 77–82.
Szewczyk B, Brański P, Wierońska JM, Pałucha A, Pilc A, Nowak G: Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol, 2002, 54, 681–685.
Szewczyk B, Kubera M, Nowak G: The role of zinc in neurodegenerative inflammatory pathways in depression, Prog Neuropsychopharmacol Biol Psychiatry, 2011, 35, 693–701.
Szewczyk B, Nowak G: Mechanisms contributing to antidepressant zinc actions. Pol J Pharmacol, 2002, 54, 587–592.
Szewczyk B, Poleszak E, Pilc A, Nowak G: Ionic glutamate modulators in depression (zinc and magnesium). In: Glutamate-based Therapies for Psychiatric Disorders, Ed. Skolnick P, Springer Basel AG, 2010, 21–38.
Szewczyk B, Poleszak E, Sowa-Kućma M, Siwek M, Dudek D, Ryszewska-Pokraoeniewicz B, Radziwoń-Zaleska M et al.: Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep, 2008, 60, 588–599.
Szewczyk B, Poleszak E, Wlaź P, Wróbel A, Blicharska E, Cichy A, Dybała M et al.: The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test: Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 323–329.
Takeda A: Movement of zinc and its functional significance in the brain. Brain Res Rev, 2000, 34, 137–148.
Takeda A, Hirate M, Tamano H, Oku N: Release of glutamate and GABA in the hippocampus under zinc deficiency. J Neurosci Res, 2003, 72, 537–542.
Takeda A, Itoh H, Tamano H, Oku N: Responsiveness to kainate in young rats after 2-week zinc deprivation. BioMetals, 2006, 19, 565–572.
Takeda A, Tamano H: Insight into zinc signaling from dietary zinc deficiency. Brain Res Rev, 2009, 62, 33–44.
Takeda A, Tamano H, Kan F, Itoh H, Oku N: Anxietylike behavior of young rats after 2-week zinc deprivation. Behav Brain Res, 2007, 177, 1–6.
Takeda A, Yamada K, Minami A, Nagano T, Oku N: Enhanced excitability of hippocampal mossy fibers and CA3 neurons under dietary zinc deficiency. Epilepsy Res, 2005, 63, 77–84.
Tamano H, Kan F, Kawamura M, Oku N, Takeda A: Behavior in the forced swim test and neurochemical changes In the hippocampus in young rats after 2-week zinc deprivation. Neurochem Int, 2009, 55, 536–541.
Tassabehij MN, Corniola RS, Alshingiti A, Levenson CW: Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav, 2008, 95, 365–369.
Valee BL: The function of metallothionein. Neurochem Int, 1995, 27, 23–33.
Virgin CE, Ha TP, Packan DR, Tombaugh GC, Yang SH, Horner HC, Sapolsky RM: Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J Neurochem, 1991, 57, 1422–1428.
Watanabe M, Tamano H, Kikuchi T, Takeda A: Susceptibility to stress in young rats after 2-week zinc deprivation, Neurochem Int, 2010, 56, 410–416.
Whittle N, Lubec G, Singewald N: Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids, 2009, 36, 147–158.
Wójcik J, Dudek D, Schlegel-Zawadzka M, Grabowska M, Marcinek A, Florek E, Piekoszewski W et al.: Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep, 2006, 58, 571–576.
Yeiser EC, Lerant AA, Casto RM, Levenson CW: Free zinc increases at the site of injury after cortical stab wounds in mature but not immature rat brain. Neurosci Lett, 1999, 277, 75–78.
Young EA, Altemus M, Lopez JF, Kocsis JH, Schatzberg AF, deBattista Ch, Zubieta J-K: HPA axis activation in major depression and response to fluoxetine: a pilot study. Psychoneuroendocrinology, 2004, 29, 1189–1204.